nominally significantp < 0.05
3g ) of genetic associations with infarcts and with blood SMAD3 levels in ADNI and MCSA revealed 6 intronic SMAD3 variants (rs71400360, rs12904527, rs12909923, rs71400361, rs35779650, rs28564777) that had nominally significant associations ( p < 0.05) with both lower risk of brain infarcts and with higher blood levels of SMAD3 .